ArticleFrontiers in genetics2023

Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy.

Annie Borch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.